BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3769 related articles for article (PubMed ID: 7328599)

  • 1. Development of new mitomycin C and porfiromycin analogues.
    Iyengar BS; Lin HJ; Cheng L; Remers WA; Bradner WT
    J Med Chem; 1981 Aug; 24(8):975-81. PubMed ID: 7328599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
    Iyengar BS; Sami SM; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1983 Jan; 26(1):16-20. PubMed ID: 6827524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C analogues with secondary amines at position 7.
    Iyengar BS; Sami SM; Tarnow SE; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1983 Oct; 26(10):1453-7. PubMed ID: 6620304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and antitumor activity of 7-substituted 1,2-aziridinomitosenes.
    Iyengar BS; Remers WA; Bradner WT
    J Med Chem; 1986 Oct; 29(10):1864-8. PubMed ID: 3761307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antineoplastic activity of 1a-formyl and 1a-thioformyl derivatives of mitomycin C and 2-methylaziridine.
    Fishbein PL; Kohn H
    J Med Chem; 1987 Oct; 30(10):1767-73. PubMed ID: 3116255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
    Holden SA; Herman TS; Teicher BA
    Radiother Oncol; 1990 May; 18(1):59-70. PubMed ID: 2113698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of hematopoietic and leukemic colony-forming cells in vivo after administration of mitomycin C or porfiromycin.
    Razek A; Valeriote F; Vietti T
    J Natl Cancer Inst; 1973 Dec; 51(6):1845-8. PubMed ID: 4765389
    [No Abstract]   [Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
    Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
    Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of 6-substituted mitosene analogues of the mitomycins.
    Casner ML; Remers WA; Bradner WT
    J Med Chem; 1985 Jul; 28(7):921-6. PubMed ID: 3925147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    EVANS JS; BOSTWICK L; MENGEL GD
    Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative stereochemistry in the aziridine ring openings of N-methylmitomycin A and 7-methoxy-1,2-(N-methylaziridino)mitosene.
    Cheng L; Remers WA
    J Med Chem; 1977 Jun; 20(6):767-70. PubMed ID: 874953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New mitomycin analogs produced by directed biosynthesis.
    Claridge CA; Bush JA; Doyle TW; Nettleton DE; Moseley JE; Kimball D; Kammer MF; Veitch J
    J Antibiot (Tokyo); 1986 Mar; 39(3):437-46. PubMed ID: 3700245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and antitumor activity of additional mitomycin A analogues.
    Sami SM; Remers WA; Bradner WT
    J Med Chem; 1989 Mar; 32(3):703-8. PubMed ID: 2918519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin C analogues with aryl substituents on the 7-amino group.
    Sami SM; Iyengar BS; Tarnow SE; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1984 May; 27(5):701-8. PubMed ID: 6425501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of C-7 substituted cyclic acetal derivatives of mitomycin C and porfiromycin against hypoxic and oxygenated EMT6 carcinoma cells in vitro and in vivo.
    Rockwell S; Keyes SR; Loomis R; Kelley M; Vyas DM; Wong H; Doyle TW; Sartorelli AC
    Cancer Commun; 1991 Jun; 3(6):191-8. PubMed ID: 2049227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-N-(mercaptoalkyl)mitomycins: implications of cyclization for drug function.
    Na Y; Wang S; Kohn H
    J Am Chem Soc; 2002 May; 124(17):4666-77. PubMed ID: 11971715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The derivation of 1a-demethylmitomycin G from mitomycin C.
    Kono M; Kasai M; Shirahata K; Morimoto M
    J Antibiot (Tokyo); 1990 Apr; 43(4):383-90. PubMed ID: 2112532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antineoplastic activity of mitosene analogues of the mitomycins.
    Hodges JC; Remers WA; Bradner WT
    J Med Chem; 1981 Oct; 24(10):1184-91. PubMed ID: 7328580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 189.